7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Exploratory analyses of HER1/EGFR, K-ras mutations and other molecular markers in tumors of patients with non-small-cell lung cancer treated with chemotherapy with or without erlotinib (Tarceva) (talent—phase iii) [slideshow]

      Read this article at

      ScienceOpen
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Oncology & Radiotherapy, Medicine

          Comments

          Comment on this article